BETA

5 Amendments of Mara BIZZOTTO related to 2016/2057(INI)

Amendment 3 #
Draft opinion
Paragraph 1
1. Believes that the opinions of European citizens voiced by petitioning the European Parliament are of fundamentally important in signalling to the European legislator issues that citizens feel concerned about, particularlyce and should be addressed by the European legislator as a matter of priority; points to the issues raised by the public concerning the inadequate distribution of medicines, the impact of the economic crisis on medical and pharmaceutical care, and issues regarding marketing procedures and patents for medicinal products;
2016/07/25
Committee: PETI
Amendment 31 #
Draft opinion
Paragraph 4
4. Recognises as key obstacles to access to medicines the lack of affordability and availability of medicines, the budgetary cuts resulting from the financial crisis, the high price of medicines and, the monopolies of large companies in the market and the impact of austerity measures on employment and the economy;
2016/07/25
Committee: PETI
Amendment 47 #
Draft opinion
Paragraph 5
5. HighlightEmphasises the negative impact of Member States’the austerity policies imposed by Member States and stresses that budgetary cuts should not prevent any EU citizen from being able to access medicines;
2016/07/25
Committee: PETI
Amendment 71 #
Draft opinion
Paragraph 8 – point 1 (new)
(1) Points to the issue of online sales of counterfeit medicines, which poses a grave threat to the health and safety of EU citizens;
2016/07/25
Committee: PETI
Amendment 80 #
Draft opinion
Paragraph 9
9. Underlines that free trade agreements such as TTIP and TiSA maywill seriously damagjeopardise Member States’ healthcare systems, paving the way for wider liberalisation and privatisation in vital sectors and further undermining the principle of universal access to healthcare;
2016/07/25
Committee: PETI